文献速递血管炎

诊断年龄影响巨细胞动脉炎患者的临床表型、治疗策略与结局:来自观察性GCAGE研究1004例患者的结果

Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients.
PubMed 文献 · Ann Rheum Dis · 2023-05-15

基于意大利风湿病学会血管炎研究组转诊中心随访的1004例巨细胞动脉炎患者,按诊断年龄分为≤64岁、65-79岁和≥80岁三组。≥80岁组颅部症状、缺血并发症和失明风险显著更高,≤64岁组大血管型更常见;年龄不影响复发时间或次数,>65岁患者主动脉瘤/夹层风险增加2-3倍,严重感染与高龄显著相关,死亡率为5.8%。

要点

  • ≥80岁诊断者失明率36.98%,高于65-79岁的18.21%和≤64岁的6.19%(p<0.0001)。
  • 大血管型巨细胞动脉炎在≤64岁组更常见,占该组65%。
  • >65岁患者随访至60个月主动脉瘤/夹层风险增加2-3倍,严重感染与高龄显著相关。

核心结论

  • 最高风险的缺血并发症、动脉瘤形成、严重感染和可能的治疗不足使巨细胞动脉炎在最高龄患者中成为极具挑战性的疾病。

研究设计与样本

  • 观察性GCAGE研究纳入意大利风湿病学会血管炎研究组转诊中心随访的巨细胞动脉炎患者,入组截至2021年11月,共1004例,平均年龄72.1±8.4岁,女性70.82%,中位随访49个月(IQR 23-91)。
  • 患者按诊断年龄分为≤64岁、65-79岁和≥80岁三组。

主要发现

  • ≥80岁组颅部症状、缺血并发症和失明风险显著高于65-79岁组和≤64岁组(失明:36.98% vs 18.21% vs 6.19%;p<0.0001)。
  • 大血管型巨细胞动脉炎在≤64岁组更常见,占该组65%。
  • 复发发生于47%的患者,年龄不影响首次复发时间,也不影响复发次数。
  • 高龄与辅助免疫抑制剂数量呈负相关。
  • >65岁患者随访至60个月时主动脉瘤/夹层风险增加2-3倍;严重感染与高龄显著相关,其他治疗相关并发症(高血压、糖尿病、骨质疏松性骨折)与年龄无显著关联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Immune and vascular ageing are proposed risk factors for giant cell arteritis (GCA). Data on the impact of age at diagnosis of GCA on the clinical presentation and course of the disease are scarce. METHODS: Patients with GCA followed at referral centres within the Italian Society of Rheumatology Vasculitis Study Group were enrolled up to November 2021. Patients were grouped according to age at diagnosis: ≤64, 65-79 and ≥80 years old. RESULTS: The study included 1004 patients, mean age 72.1±8.4, female 70.82%. Median follow-up duration was 49 (IQR 23-91) months. Patients in the oldest group (≥80 years) had significantly more cranial symptoms, ischaemic complications and risk for blindness compared with the groups 65-79 and ≤64 years (blindness: 36.98% vs 18.21% vs 6.19%; p<0.0001). Large-vessel-GCA was more frequent in the youngest group (65% of patients). Relapses occurred in 47% of patients. Age did not influence the time to first relapse, nor the number of relapses. Older age was negatively associated with the number of adjunctive immunosuppressants. Patients >65 years old had 2-3 fold increased risk for aortic aneurysm/dissection up to 60 months follow-up. Serious infections, but not other treatment-related complications (hypertension, diabetes, osteoporotic fractures), were significantly associated with older age. Mortality occurred in 5.8% of the population with age >65, cranial and systemic symptoms as independent risk factors. CONCLUSIONS: The highest risk of ischaemic complications, aneurysm development, serious infections and the possible undertreatment make of GCA a very challenging disease in the oldest patients.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Monti S, Milanesi A, Klersy C, et al. Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients. Ann Rheum Dis. 2023. PMID: 37188498. doi:10.1136/ard-2023-223895

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。